| Name | TBC1 domain family member 3G |
| Description | Predicted to enable GTPase activator activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nA careful review of the provided abstracts did not reveal any mention of TBC1D3G. Instead, the abstracts consistently focus on describing the function of Mnt—a Max‐interacting transcriptional repressor that acts as an antagonist to c‑Myc. Mnt competes with c‑Myc for binding with the obligate partner Max at E‑box sequences in gene promoters, where it counterbalances c‑Myc–dependent transcriptional activation. Under normal conditions, Mnt occupancy helps to repress genes involved in cell cycle progression and apoptosis, whereas displacement by c‑Myc–Max complexes triggers transcription of these target genes to promote cell proliferation and, under some circumstances, oncogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe studies further demonstrate that the precise balance between Mnt–Max and c‑Myc–Max complexes is critical for normal cell cycle entry, with Mnt imposing a repression that restricts premature S‑phase entry and excessive proliferation. In various experimental models, conditional deletion or knockdown of Mnt leads to deregulated cell cycle progression, enhanced apoptosis, and even transformation in conjunction with oncogenic signals. In some contexts, however, loss of Mnt can also have tumor‐suppressive effects by increasing apoptosis through reactive oxygen species or by perturbing T‑cell homeostasis; this underscores a context‐dependent role for Mnt in modulating both proliferation and cell death."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional investigations highlighted in these abstracts reinforce that Mnt’s control over Myc function extends to various biological settings—including fibroblast cell cycling, T‑cell activation, and differentiation—as well as to pathological conditions such as tumorigenesis. For example, studies show that the modulation of Mnt levels can either facilitate or hinder Myc‑driven oncogenesis, depending on cellular context, while interactions with other Myc antagonists (like Mxd4) further fine‐tune outcomes related to cell survival. Although these reports enhance our understanding of the Myc/Mnt balance in cell regulation, they do not address or provide functional insights regarding TBC1D3G."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Peter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-oka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/emboj/cdg442"}], "href": "https://doi.org/10.1093/emboj/cdg442"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12970171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12970171"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jonas A Nilsson, Kirsteen H Maclean, Ulrich B Keller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.24.4.1560-1569.2004"}], "href": "https://doi.org/10.1128/MCB.24.4.1560-1569.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14749372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14749372"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "William Walker, Zi-Qiang Zhou, Sara Ota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mnt-Max to Myc-Max complex switching regulates cell cycle entry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200411013"}], "href": "https://doi.org/10.1083/jcb.200411013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15866886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15866886"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kazuhito Toyo-oka, Shinji Hirotsune, Michael J Gambello, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddh116"}], "href": "https://doi.org/10.1093/hmg/ddh116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15028671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15028671"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Heping Yang, Tony W H Li, Kwang Suk Ko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.22720"}], "href": "https://doi.org/10.1002/hep.22720"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19086036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19086036"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jason M Link, Sara Ota, Zi-Qiang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1206406109"}], "href": "https://doi.org/10.1073/pnas.1206406109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23150551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23150551"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nikita Popov, Therese Wahlström, Peter J Hurlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mnt transcriptional repressor is functionally regulated during cell cycle progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208961"}], "href": "https://doi.org/10.1038/sj.onc.1208961"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16103876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16103876"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shala Dezfouli, Antony Bakke, Jie Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.26.6.2080-2092.2006"}], "href": "https://doi.org/10.1128/MCB.26.6.2080-2092.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16507988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16507988"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nicole A Vasilevsky, Carl E Ruby, Peter J Hurlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.201040449"}], "href": "https://doi.org/10.1002/eji.201040449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21400495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21400495"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Raquel Bello-Morales, María C de Marco, Juan Francisco Aranda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the MAL2-positive compartment in oligodendrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2009.08.003"}], "href": "https://doi.org/10.1016/j.yexcr.2009.08.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19683524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19683524"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Peter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-Oka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence of mnt-myc antagonism revealed by mnt gene deletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2004)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14712062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14712062"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Kirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mnt modulates Myc-driven lymphomagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2017.131"}], "href": "https://doi.org/10.1038/cdd.2017.131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28800127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28800127"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hai Vu Nguyen, Cassandra J Vandenberg, Mikara R Robati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-023-01119-y"}], "href": "https://doi.org/10.1038/s41418-023-01119-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36755068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36755068"}]}]}]}
|
| NCBI Gene ID | 101060321 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TBC1D3G has 577 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.
Click the + buttons to view associations for TBC1D3G from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TBC1D3G gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TBC1D3G gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TBC1D3G gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TBC1D3G protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TBC1D3G gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TBC1D3G gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TBC1D3G gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TBC1D3G gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TBC1D3G gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TBC1D3G gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TBC1D3G gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TBC1D3G gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TBC1D3G gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TBC1D3G gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TBC1D3G protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TBC1D3G protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TBC1D3G protein from the WikiPathways Pathways 2024 dataset. | |